Journal of Shanghai Jiao Tong University (Medical Science) >

2021 , Vol. 41 >Issue 3: 314 - 319

DOI: https://doi.org/10.3969/j.issn.1674-8115.2021.03.005

Basic research

Expression patterns of interferon regulatory factor 2 binding protein 2 during the early embryonic development of zebrafish

  • Hai-hong WANG ,
  • Shuo GAO ,
  • Jun ZHU ,
  • Jun ZHOU
Expand
  • Sino-French Research Center for Life Sciences and Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China

Received date: 2020-04-01

  Online published: 2021-04-06

Fold

Abstract

Objective

·To explore the expression similarities and differences of the two paralogs of interferon regulatory factor 2 binding protein 2 (irf2bp2) gene (irf2bp2a and irf2bp2b) during the early embryonic development of zebrafish.

Methods

·Zebrafish embyos at different developmental stages (embryonic and larval stages) were chosen as research object. The mRNA whole mount in situ hybridization was used to detect the temporal and spatial expression patterns of irf2bp2a and irf2bp2b, and real-time quantitative PCR (qPCR) was used to detect their expression levels.

Results

·Although irf2bp2a and irf2bp2b shared similar expression patterns in the nervous system, eye and pectoral fin, irf2bp2a and irf2bp2b were specifically expressed in liver and stannius corpuscles, respectively, suggesting their expressions were quite unique in certain organs. The results of qPCR showed that both irf2bp2a and irf2bp2b were expressed in the early embryonic development stage, but their expression levels were different.

Conclusion

·Although the functional domains of irf2bp2a and irf2bp2b are highly conserved, the two paralogs of zebrafish irf2bp2 display some distinctions in the expression patterns during the early embryonic development of zebrafish, which suggests that their functions might not be redundant.

Key words： interferon regulatory factor 2 binding protein 2 (irf2bp2); zebrafish embyo; expression pattern; mRNA whole mount in situ hybridization; real-time quantitative PCR (qPCR)

Cite this article

Hai-hong WANG , Shuo GAO , Jun ZHU , Jun ZHOU . Expression patterns of interferon regulatory factor 2 binding protein 2 during the early embryonic development of zebrafish[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2021 , 41(3) : 314 -319 . DOI: 10.3969/j.issn.1674-8115.2021.03.005

References

1 Childs KS, Goodbourn S. Identification of novel co-repressor molecules for interferon regulatory factor-2[J]. Nucleic Acids Res, 2003, 31(12): 3016-3026.
2 Yeung KT, Das S, Zhang J, et al. A novel transcription complex that selectively modulates apoptosis of breast cancer cells through regulation of FASTKD2[J]. Mol Cell Biol, 2011, 31(11): 2287-2298.
3 Sécca C, Faget DV, Hanschke SC, et al. IRF2BP2 transcriptional repressor restrains naive CD4 T cell activation and clonal expansion induced by TCR triggering[J]. J Leukoc Biol, 2016, 100(5): 1081-1091.
4 Bruno A, Boisselier B, Labreche K, et al. Mutational analysis of primary central nervous system lymphoma[J]. Oncotarget, 2014, 5(13): 5065-5075.
5 Yin CC, Jain N, Mehrotra M, et al. Identification of a novel fusion gene, IRF2BP2-RARA, in acute promyelocytic leukemia[J]. J Natl Compr Canc Netw, 2015, 13(1): 19-22.
6 Shimomura Y, Mitsui H, Yamashita Y, et al. New variant of acute promyelocytic leukemia with IRF2BP2-RARA fusion[J]. Cancer Sci, 2016, 107(8): 1165-1168.
7 Jovanovic JV, Chillón MC, Vincent-Fabert C, et al. The cryptic IRF2BP2-RARA fusion transforms hematopoietic stem/progenitor cells and induces retinoid-sensitive acute promyelocytic leukemia[J]. Leukemia, 2017, 31(3): 747-751.
8 Mazharuddin S, Chattopadhyay A, Levy MY, et al. IRF2BP2-RARA t(1;17)(q42.3;q21.2) APL blasts differentiate in response to all-trans retinoic acid[J]. Leuk Lymphoma, 2018, 59(9): 2246-2249.
9 Stadhouders R, Cico A, Stephen T, et al. Control of developmentally primed erythroid genes by combinatorial co-repressor actions[J]. Nat Commun, 2015, 6: 8893.
10 Teng AC, Kuraitis D, Deeke SA, et al. IRF2BP2 is a skeletal and cardiac muscle-enriched ischemia-inducible activator of VEGFA expression[J]. FASEB J, 2010, 24(12): 4825-4834.
11 Fang J, Li T, Zhu X, et al. Control of pathological cardiac hypertrophy by transcriptional corepressor IRF2BP2 (interferon regulatory factor-2 binding protein 2) [J]. Hypertension, 2017, 70(3): 515-523.
12 Chen HH, Keyhanian K, Zhou X, et al. IRF2BP2 reduces macrophage inflammation and susceptibility to atherosclerosis[J]. Circ Res, 2015, 117(8): 671-683.
13 Berron-Ruiz L. Immunological alterations in common variable immunodeficiency[J]. Rev Alerg Mex, 2017, 64(1): 87-108.
14 Keller MD, Pandey R, Li D, et al. Mutation in IRF2BP2 is responsible for a familial form of common variable immunodeficiency disorder[J]. J Allergy Clin Immunol, 2016, 138(2): 544-550. e4.
15 Hari A, Cruz SA, Qin Z, et al. IRF2BP2-deficient microglia block the anxiolytic effect of enhanced postnatal care[J]. Sci Rep, 2017, 7(1): 9836.
16 Cruz SA, Hari A, Qin Z, et al. Loss of IRF2BP2 in microglia increases inflammation and functional deficits after focal ischemic brain injury[J]. Front Cell Neurosci, 2017, 11: 201.
17 Ma YL, Xia JL, Gao X. Suppressing Irf2bp2 expressions accelerates metabolic syndrome-associated brain injury and hepatic dyslipidemia[J]. Biochem Biophys Res Commun, 2018, 503(3): 1651-1658.
Options
Outlines

/

〈 〉